In 2017, there are expected to be approximately 161,000 new prostate cancer diagnoses and approximately 26,700 prostate cancer deaths. The screening tests exist for the prostate cancer can’t conclude which cancer will cause harm and which ones will not. This article provides a brief view about the screening approaches that can be used for prostate cancer. PROBLEMS WITH CURRENT SCREENING AND TREATMENT: Prostate cancer can be categorized in two types.
In one form, the prostate cancer progress slowly and probably causes less harm but in other form, it grows fast and can spread to other parts of the body leading to death. The screening tests available till date can’t conclude which cancer will cause harm and which ones will not. These mean men with slow growing cancers may get treatment that they don’t need. Another issue is that the tests may give false positive result or false negative…
